| Biotechnology Industry | Healthcare Sector | Mr. Lin Cao CEO | SSE Exchange | CNE100004ZK3 ISIN |
| CN Country | 2,700 Employees | 3 Jun 2026 Last Dividend | 3 Jun 2026 Last Split | - IPO Date |
Nanjing Vazyme Biotech Co., Ltd is a company specialized in providing advanced technology solutions for the fields of life science, biomedicine, and in vitro diagnostics. Since its inception in 2012, Vazyme Biotech has been committed to innovation and excellence in the development of high-quality reagents and products for molecular biology research, next-generation sequencing (NGS), molecular diagnostics, and bio-medicine. Based in Nanjing, China, the company leverages its expertise in enzyme engineering and bio-manufacturing to support researchers and professionals worldwide, facilitating breakthroughs in scientific research and healthcare.